Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 105-112

  Gentile, Daniela M ^a   Tomlinson, Emma S ^a   Maggs, James L ^a   Park, B Kevin ^a   Back, David J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXY 9ALPHA FLUOROANDROSTA 1,4 DIENE 11BETA HYDROXY 16ALPHA METHYL 3,17 DIONE; 6ALPHA HYDROXYDEXAMETHASONE; 9ALPHA FLUOROANDROSTA 1,4 DIENE 11BETA HYDROXY 16ALPHA METHYL 3,17 DIONE; DEXAMETHASONE; ELLIPTICINE; FURAFYLLINE; GESTODENE; KETOCONAZOLE; SULFAPHENAZOLE; TOLBUTAMIDE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ARTICLE; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; IMMUNOBLOTTING; INHIBITION KINETICS; LIVER METABOLISM; LIVER MICROSOME; MICHAELIS CONSTANT; PRIORITY JOURNAL; STEROID METABOLISM;

CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROXYLATION; MICROSOMES, LIVER;

EID: 0030435332     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ABEL, S. M. AND BACK, D. J.: Cortisol metabolism in vitro. III. Inhibition of microsomal 6β-hydroxylase and cytosolic 4-ene-reductase. J. Steroid Biochem. Mol. Biol. 46: 827-832, 1993.
2. ABEL, S. M., BACK, D. J., MAGGS, J. L. AND PARK, B. K.: Cortisol metabolism by human liver in vitro. IV. Metabolism of 9α-fluorocortisol by human liver microsomes and cytosol. J. Steroid Biochem. Mol. Biol. 46: 833-838, 1993.
3. ABEL, S. M., MAGGS, J. L., BACK, D. J. AND PARK, B. K.: Cortisol metabolism by human liver in vitro. I. Metabolite identification and inter-individual variability. J. Steroid Biochem. Mol. Biol. 43: 713-719, 1992.
4. BÖCKER, R., KLEINGEIST, B., EICHHORN, M. AND LEPPER, H.: In vitro interactions of contraceptive steroids with human liver cytochrome P450 enzymes. Adv. Contracept. 7: 140-148, 1991.
5. BROOKS, C. J. W. AND NORYMBERSKI, J. K.: The oxidation of corticosteroids with sodium bismuthate. Biochem. J. 55: 371-378, 1953.
6. BUSH, I. E. AND MAHESH, V. B.: Metabolism of 11-oxygenated steroids. Biochem. J. 93: 236-255, 1964.
7. BUTLER, J. AND GRAY, C. H.: The metabolism of betamethasone. J. Endocr. 46: 379-390, 1970.
8. 6-6-acyloxybetamethasone. Drug Res. 32: 317-322, 1982.
9. DÜSTERBERG, R., TACK, J. W., KRAUSE, W. AND HUMPEL, M.: Pharmacokinetics and biotransformation of gestodene in man. In Gestodene. Development of a New Gestodene-Containing Low-Dose Oral Contraceptive, ed. by M. Elstein, pp. 35-44, Parthenon, Carnforth, 1987.
10. ENGLISH, J., CHARKRABORTY, J. AND MARKS, V.: The metabolism of dexamethasone in the rat. Effect of phenytoin. J. Steroid Biochem. 6: 65-68, 1975.
11. GAIGNAGE, PH., LOGNAY, G., MAHLIER, M., SEVERIN, M. AND DREZE, PH.: Synthèse de dérivés de la dexamethasone. Purification par chromatographie liquide préparative et caractérisation par spectrométrie de masse complée à la chromatographie liquide haute performance. Bull. Rech. Agron. Gembloux 25: 345-356, 1990.
12. GED, C., ROUILLON, J. M., PICHARD, L., COMBALBERT, J., BRESSOT, N., BOIRES, P., MICHEL, H., BEAUNE, P. AND MAUREL, P.: The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P-450 3A induction. Br. J. Clin. Pharmacol. 28: 373-387, 1989.
13. GILLETTE, J. R., DARBYSHIRE, J. F AND SUGIYAMA, K.: Theory for the observed isotope effects on the formation of multiple products by different kinetic mechanisms of cytochrome P450 enzymes. Biochemistry 33: 2927-2937, 1994.
14. GONZALEZ, F. J.: Human Cytochrome P450. Problems and prospects. Trends Pharmacol. Sci. 13: 346-352, 1992.
15. GUENGERICH, F. P.: Mechanism-based inactivation of human liver microsomal cytochrome P450IIIA4 by gestodene. Chem. Res. Toxicol. 3: 363-371, 1990.
16. HALPERT, J. R., GUENGERICH, F. P., BEND, J. R. AND CORREIA, M. A.: Selective inhibitors of cytochromes P450. Toxicol. Appl Pharmacol. 125: 163-175, 1994.
17. HAQUE, N., THRASHER, K., WERK, E. E., KNOWLES, H. C. AND SHOLITON, L. J.: Studies on dexamethasone metabolism in man: Effect of diphenylhydantoin. J. Clin. Endocr. 34: 44-50, 1972
18. HARGREAVES, J. A., JEZEQUEL, S. AND HOUSTON, J. B.: Effect of azole antifungals on human microsomal metabolism of diclofenac and midazolam. Br. J. Clin. Pharmacol. 38: 175, 1994.
19. HYLAND, R., JONES, B., LOGAN, A., MANSFIELD, R., MOORE, R. AND SMITH, D.: Production of a human CYP3A antibody from multiple peptide sequences. Br. J. Clin. Pharmacol. 40: 179-180, 1995.
20. KOLLMAN, P. A., GIANNI, D. D., DUAX, W. L., ROTHENBERG, S. AND WOLFF, M. E.: Quantitation of long-range effects in steroids by molecular orbital calculations. J. Am. Chem. Soc. 95: 2869-2873, 1973.
21. KUNZE, K. L. AND TRAGER, W. F.: Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem. Res. Toxicol. 6: 649-656, 1993.
22. LAEMMLI, U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227: 680-685, 1970.
23. LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein determination with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
24. MANSUY, D.: Cytochromes P450 and model systems: Great diversity of catalyzed reactions. Pure Appl. Chem. 66: 737-744, 1994.
25. MAURICE, M., PICHARD, L., DAUJAT, M., FABRE, I., JOYEUX, H., DOMERGUE, J. AND MAUREL, P.: Effects of imidazole derivatives on cytochromes P-450 from human hepatocytes in primary culture. Fed. Am. Soc. Exp. Biol. 6: 752-758, 1992.
26. MINAGAWA, K., KASUYA, Y., BABA, S., KNAPP, G. AND SHELLY, J. P.: Identification and quantification of 6β-hydroxydexamethasone as a major urinary metabolite of dexamethasone in man. Steroids 47: 175-188, 1986.
27. MURRAY, M.: P450 enzymes, inhibition mechanisms, genetic regulation and effects of liver disease. Clin. Pharmacokinet. 23: 132-134, 1992.
28. NEWTON, D. J., WANG, R. W. AND LU, A. Y. H.: Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Dispos. 23: 154-158, 1995.
29. PURBA, H. S., MAGGS, J. L., ORME, M. L'E., BACK, D. J. AND PARK, B. K.: The metabolism of 17α-ethinylestradiol by human liver microsomes: Formation of catechol and chemically reactive metabolites. Br. J. Clin. Pharmacol. 23: 447-453, 1987.
30. RILEY, P. AND HANZLIK, R. P.: Electron transfer in P450 mechanisms. Microsomal metabolism of cyclopropylbenzene and p-cyclopropanisole. Xenobiotica 24: 1-16, 1994.
31. THÀLEN, A. AND WICKSTROM, L.-I.: Synthesis and structure elucidation of 6α- and 6β-hydroxylated budesonide and related corticosteroids. Acta Pharm. Suec. 21: 145-162, 1984.
32. TOWBIN, H., STACHELIN, T. AND GORDON, J.: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Sci. U.S.A. 76: 4350-4354, 1979.
33. WARD, S. AND BACK, D. J.: Metabolism of gestodene in human liver microsomes in vitro. J. Steroid Biochem. 46: 235-243, 1993.
34. WAXMAN, D. J., ATTISANO, C., GUENGERICH, F. P. AND LAPENSON, D. P.: Human liver microsomal steroid metabolism. Identification of the major microsomal steroid hormone 6β hydroxylase cytochrome P450 enzyme. Arch. Biochem. Biophys. 263: 424-436, 1988.
35. WAXMAN, D. J., LAPENSON, D. P., AOYAMA, T., GELBION, H. V., GONZALEZ, F. J. AND KORZEKWA, K.: Steriod hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Biochem. Biophys. 290: 160-166, 1991.
36. WEBB, J. L.: Determination of mechanisms and constants of inhibition. In Enzyme and Metabolic Inhibitors, pp. 149-191, Academic Press, New York, 1963.
37. WETTSTEIN, A.: Chemistry of fluorosteroids and their hormonal activities. In Carbon-Fluorine Compounds. Chemistry, Biochemistry and Biological Activities, A Ciba Foundation Symposium, ed. by A. Escenmoser, pp. 291-301, Elselvier, Amsterdam, 1972.